The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

Novo Nordisk ( NVO 6.12%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky ...

Healthcare & Pharmaceuticalscategory· June 10, 2025 Novo Nordisk starts new CagriSema weightloss drug trial Novo Nordisk has launched a new late-stage trial for its experimental next-generation ...

The new multiyear agreement will allow the Danish pharma to use Gefion’s computational power to “process vast datasets” with ...

Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...